Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib plus glucocorticoids for polymyalgia rheumatica
ChiCTR2100053063Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tofacitinib in polymyalgia rheumatica (PMR) (2 arms), sponsored by Tongji Hospital. Primary endpoint: Effectiveness. Started Nov 2021; status: recruiting.
02
Drugs
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on ChiCTR2100053063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053063.